LPL Financial
PYXS icon

LPL Financial’s Pyxis Oncology PYXS Stock Holding History

LPL Financial’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49K Sell
33,554
-1,548
-4% -$2.33K ﹤0.01% 5791
2025
Q4 		$40.4K Buy
35,102
+21,100
+151% +$74.4K ﹤0.01% 5727
2025
Q3 		$31.1K Sell
14,002
-197
-1% -$284 ﹤0.01% 5694
2025
Q2 		$15.6K Sell
14,199
-1,900
-12% -$2.14K ﹤0.01% 5496
2025
Q1 		$15.8K Sell
16,099
-6,500
-29% -$8.67K ﹤0.01% 5282
2024
Q4 		$35.3K Buy
22,599
+7,800
+53% +$22.5K ﹤0.01% 5143
2024
Q3 		$54.3K Buy
+14,799
New +$51.8K ﹤0.01% 4989
2024
Q1 		– Sell
-11,429
Closed -$20.6K – 5004
2023
Q4 		$20.6K Buy
+11,429
New +$19.6K ﹤0.01% 4730
2023
Q2 		– Sell
-13,664
Closed -$54.8K – 4662
2023
Q1 		$54.8K Buy
+13,664
New +$27.3K ﹤0.01% 4291

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's PYXS Position: Q1 2026 in Review

LPL Financial reduced its Pyxis Oncology (PYXS) stake by 4.4% in Q1 2026, selling an estimated $2.33K and leaving 33,554 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #5791.

LPL Financial first reported a position in PYXS in Q1 2023 and has held it in 9 quarters since. The position peaked at $54.8K in Q1 2023. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • LPL Financial held 33,554 shares of Pyxis Oncology worth $49K as of Q1 2026.
  • LPL Financial sold 1,548 Pyxis Oncology shares in Q1 2026, an estimated $2.33K.
  • Pyxis Oncology made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5791 holding.
  • LPL Financial first reported a position in Pyxis Oncology in Q1 2023 and has held it in 9 quarters since.
  • LPL Financial's Pyxis Oncology position peaked at $54.8K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.